Another study showed that CaMKII dysregulation in Alzheimer’s patients may be a modulator of toxicity in Alzheimer’s disease, a dementia characterized by aberrant calcium signaling, synapse and neuronal loss, and impaired memory60. The gene discussed is CAMK2G; the disease is early-onset autosomal dominant Alzheimer disease.